Covered recipient · General Payments record
RICHARD A GORDON
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2018–2024
$2,046.81
- Reported across 95 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $900.67 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Corium, Inc. | $559.84 | 17 |
| Novo Nordisk AS | $172.96 | 9 |
| DEXCOM, INC. | $48.72 | 2 |
| Lilly USA, LLC | $42.13 | 2 |
| Janssen Pharmaceuticals, Inc | $22.63 | 1 |
| ALK-Abello, Inc | $20.65 | 1 |
| Acerta Pharma LLC | $20.20 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ALK-Abello, Inc | $20.65 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099891137 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.20 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105269443 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.54 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118256990 | CMS |
| Corium, LLC | $29.66 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100075475 | CMS |
| Corium, LLC | $32.19 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100072755 | CMS |
| Corium, LLC | $32.78 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100072109 | CMS |
| Corium, LLC | $33.69 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100071355 | CMS |
| Corium, LLC | $33.38 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100071599 | CMS |
| Corium, LLC | $33.69 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100071375 | CMS |
| Corium, LLC | $34.39 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100205644 | CMS |
| Corium, LLC | $30.06 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100200969 | CMS |
| Corium, LLC | $34.40 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100205660 | CMS |
| Corium, LLC | $33.54 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100204846 | CMS |
| Corium, LLC | $33.54 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100204852 | CMS |
| Corium, LLC | $34.47 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100205736 | CMS |
| Corium, LLC | $33.83 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100205178 | CMS |
| Corium, LLC | $30.60 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100201612 | CMS |
| Corium, LLC | $31.88 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100203096 | CMS |
| Corium, LLC | $34.89 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100218071 | CMS |
| Corium, LLC | $32.85 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100218145 | CMS |
| Dexcom, Inc. | $24.48 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153330765 | CMS |
| Dexcom, Inc. | $24.24 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153330767 | CMS |
| Janssen Pharmaceuticals, Inc | $22.63 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078141921 | CMS |
| Lilly USA, LLC | $24.71 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135364579 | CMS |
| Lilly USA, LLC | $17.42 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135365938 | CMS |
| Novo Nordisk Inc | $18.03 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097245752 | CMS |
| Novo Nordisk Inc | $20.36 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097272459 | CMS |
| Novo Nordisk Inc | $17.97 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097779086 | CMS |
| Novo Nordisk Inc | $17.97 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096740168 | CMS |
| Novo Nordisk Inc | $15.72 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096914260 | CMS |
| Novo Nordisk Inc | $22.64 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097348721 | CMS |
| Novo Nordisk Inc | $21.03 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096836250 | CMS |
| Novo Nordisk Inc | $16.78 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096612460 | CMS |
| Novo Nordisk Inc | $22.46 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096910341 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.